Atlas Trials

Clinical Study for Combined Analysis of CTC and Exosomes on Predicting the Efficacy of Immunotherapy in Patients With Hepatocellular Carcinoma

Clinical trial NCT05575622 · UNKNOWN

Trial details

NCT number
NCT05575622
Sponsor
Zhongnan Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatocellular Carcinoma
Start date
2023-01-01
Primary completion
2024-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.